"These drugs are so expensive -- $14,000-$15,000 a year. Cardiologists have never been faced with a situation like this," said DeMaria, who noted that the prices quoted for the PCSK9 drugs were similar to the costs of cancer drugs but with an important difference: "these drugs are forever. Forever."
Journal reverses acceptance of study linking vaccines to autism
Il y a 14 heures